For investors looking for a dependable source of passive income, a methodical screening process is needed to distinguish truly lasting dividend payers from risky high-yield situations. A typical plan involves selecting for companies that have both a good dividend history and are fundamentally strong. This requires looking past the stated yield to evaluate the basic financial condition and earnings power of the firm. A stock that performs well in these areas points to a business able to keep and possibly raise its dividend over many years, including during downturns. One company identified by such a strict screen is ResMed Inc (NYSE:RMD), a global frontrunner in digital health for sleep apnea and respiratory care.
Dividend Profile: Stability and Growth
The central attraction for dividend investors is ResMed’s proven dedication to giving capital back to shareholders. The company’s dividend history is marked by dependability and consistent expansion, which can be more important than a large but unstable yield.
- Track Record and Growth: ResMed has built a dependable history, having paid and regularly raised its dividend for over ten years. This record is important, as it shows management’s focus on shareholder returns across different market environments. The dividend is increasing at a sound yearly rate of about 6.33% over the last five years.
- Sustainable Payout: Most critically, the dividend seems very sustainable. The payout ratio, the part of earnings distributed as dividends, is a modest 22.25%. This low figure shows the company keeps most of its earnings to fund business reinvestment, reduce debt, or seek other options, all while easily affording the dividend. The basic analysis also states that earnings are rising quicker than the dividend, supporting the payout's durability.
- Yield in Context: With a dividend yield of 0.94%, ResMed might not draw investors seeking the largest immediate income. Still, this yield is strong for its sector and is supported by the good fundamentals of growth and security. For a plan centered on lasting, increasing income instead of highest present yield, this history is attractive.
Foundational Strength: Profitability and Financial Health
A lasting dividend is only as good as the company that provides it. This is why selecting for good profitability and condition is a key step in the method, it confirms the dividend is not being financed by borrowing or by harming the company's prospects. ResMed performs very well in these categories, offering a firm base for its shareholder returns.
- Strong Profitability: ResMed receives a high ChartMill Profitability Rating of 9 out of 10. Important figures like Return on Equity (23.51%) and Operating Margin (34.11%) rank it with the best in the Health Care Equipment field. High profitability indicates the company produces sufficient earnings from its activities, which is the main source of money for a lasting dividend.
- Sound Financial Health: The company also gets a good 8 out of 10 for Financial Health. Its balance sheet is prudent, with a low Debt-to-Equity ratio of 0.06 and an Altman-Z score of 12.92, showing a very small short-term chance of financial trouble. Also, its Debt-to-Free-Cash-Flow ratio is only 0.37, meaning it could erase all its debt in under five months using its existing cash flow. This financial strength means the dividend is not likely to be endangered by balance sheet issues.
Valuation and Growth Considerations
While the main goal for dividend investors is income dependability, overall valuation and growth potential matter for total return. ResMed shows a varied but sensible view here. Its Price-to-Earnings ratio is a bit under the industry average, indicating relative value within its group. Analysts project continued, though slowing, growth in both revenue and earnings per share in the high single-digits to low double-digits. This growth forecast supports the chance for future dividend raises. The full details of these elements, including comparisons to industry and market standards, are in the complete ChartMill Fundamental Analysis Report for RMD.
Conclusion
ResMed Inc stands as a strong example for a quality dividend investing method. By selecting for high dividend ratings together with good profitability and condition, the screening process finds companies made for endurance. RMD’s ten-year history of dependable and rising payments, supported by very good operational margins and a firm balance sheet, fits this plan well. It shows that a solid yield, when paired with basic strength and growth, can be a valuable part of a long-term income portfolio. Investors using this method are not just purchasing a yield, they are investing in a financially sound business that can reward shareholders steadily.
For investors wanting to examine other companies that fit similar standards of good dividends, profitability, and financial condition, you can see the full screen results through this link: Best Dividend Stocks Screen.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer to buy or sell any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.